UPDATE 2-FTSE 100 ends week lower after week AstraZeneca, RBS results

* FTSE 100 down 0.6%, FTSE 250 up 0.5%
* AstraZeneca drops after profit miss
* Coronavirus spread fuels stimulus hopes

(Adds company news items, updates share moves)
By Muvija M and Shashwat Awasthi
Feb 14 (Reuters) - UK blue-chip shares fell for a second day
on Friday after AstraZeneca and RBS reported underwhelming
results, while investors remained unsettled because of concerns
over the impact of the coronavirus outbreak on the global
economy.
The FTSE 100 index .FTSE ended the Valentine's Day trading
session 0.6% lower, down 0.8% for the week, while the midcap
bourse .FTMC rose 0.5% as it drew strength from the pound.
Global markets are expecting stimulus from central banks as
new coronavirus showed no signs of peaking. U.S. Federal Reserve
Chair Jerome Powell had last week warned that the economic
impact from the outbreak could spill over globally. The FTSE 100, with its larger exposure to commodity prices,
has lagged its European counterpart, which has hovered at record
high levels for most of the week, as investors shrugged off
fears over the new virus.
London's main index has also been derailed as commodity
prices take a hit from slower demand from China post the health
crisis.
Among corporate news, AstraZeneca AZN.L dropped over 4.3%
as its quarterly earnings failed to match up to market
expectations. "Corporate updates triggered the declines in the pharma
sector as well as the banking industry. Dealers are still
worried about the health emergency in China as the situation
isn't showing any signs of improving," CMC Markets analyst David
Madden, said.
Royal Bank of Scotland RBS.L fell 6.8%, ending the day at
the bottom of the bluechip index, after its new top boss set out
a new strategy that included cutting back the size of its
loss-making investment bank and renaming the company NatWest.
"Every rose has its thorn; scratch beneath every RBS
quarterly update and you'll find a sting or two," Markets.com
analyst Neil Wilson wrote in note.
Warehousing specialist Segro SGRO.L outperformed the
index, rising 1.5% and hitting a fresh high after it reported a
jump in full-year profit and increased its dividend.
Among smaller stocks, biotechnology company Novacyt NCYT.L
jumped 29% after it said it would launch a certified test for
the new coronavirus next week. Mosman Oil and Gas MSMN.L tanked 36% after it announced
capital raise and updated the markets on its corporate strategy,
which included the sale of some of its projects.